-
-
7 . Periodical
Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial
- 저자
- by Crowell, Trevor A; Colby, Donn J; Pinyakorn, Suteeraporn; Sacdalan, Carlo; Pagliuzza, Amélie, et al.
- 소스
- The Lancet HIV; May 2019, Vol. 6 Issue: 5 pe297-e306, 10p